As a Principal at Remiges Ventures, Kazuhiko leverages over 20 years of experience in drug discovery, licensing, and R&D from roles at Boehringer Ingelheim and Mochida Pharmaceutical. He holds a Ph. D. from Nagoya City University and focuses on early-stage life science investments.
His specific investment and research expertise lies in complex therapeutic areas, including the central nervous system (CNS), pain, and immunology.
Read the full overview →Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.